BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-66@pharmaconomics
DTSTAMP:20260707T034540Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:AUGX Phase 3 — AVTX-803 (estimated date)
DESCRIPTION:Phase 3 trial results for AVTX-803 in Leukocyte Adhesion Deficiency are due ~ Dec 31\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://clinicaltrials.gov/study/NCT05754450\n\nTrack it: https://www.pharmaconomics.com/e/66
URL:https://www.pharmaconomics.com/e/66
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:AUGX catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR